ddPCR has been shown to accurately detect alterations of intertest in non-CNS tumor blood/plasma samples including BRAF V600E alterations in melanomas and EGFR mutations in non-small cell lung cancer, both have targeted treatments available [55,56]. The gene discussed is BRAF; the disease is melanoma.